FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803400551> ?p ?o ?g. }

• W2803400551 endingPage "1404" @default.
• W2803400551 startingPage "1397" @default.
• W2803400551 abstract "Background: It is unclear whether Cetuximab (CTX) or Nimotuzumab (NTZ) concurrent with radiotherapy delivers equivalent or improved results with fewer toxicities over standard cisplatin (CDDP) concurrent with radiotherapy in locally advanced nasopharyngeal carcinoma (NPC). Methods: The strategy involved searching the PubMed, Embase, Cochrane Library, China National Knowledge Internet Web, Wanfang and Chinese Biomedical databases. Controlled clinical trials that compared concurrent CTX/NTZ with radiotherapy versus CDDP with radiotherapy in local-regionally advanced NPC were included. Results: In all, 1,239 patients in six clinical trials were included in the analysis. The hazard ratios (HRs) between the CTX/NTZ and CDDP groups were 1.01 (95% confidence interval (CI) 0.63-1.64), 1.06 (95% CI 0.50-2.25), 1.04 (95% CI 0.61-1.76), and 1.05 (95% CI 0.73-1.50) for overall survival, local-regional failure-free survival, distant metastasis failure-free survival, and disease-free survival, respectively. Significant differences were found in the incidences of grade 3-4 anaemia [Risk ratio (RR) 0.11 95% CI 0.02-0.58], grade 3-4 neutropenia (RR 0.23 95% CI 0.12- 0.44), grade 3-4 thrombocytopenia (RR 0.31 95% CI 0.12- 0.79), and grade 3-4 vomiting (RR 0.04 95% CI 0.00-0.29) in favour of the CTX/NTZ group. However, the patients in the CTX/NTZ group experienced a higher incidence of grade 3-4 skin rash (RR 6.45 95% CI 3.84-10.84). Conclusions: Regarding the efficacy and side effects, the combination of CTX / NTZ and radiotherapy may be an alterative treatment regimen of standard CDDP concurrent with radiotherapy in local-regionally advanced NPC, especially in patients who cannot tolerate or who refuse chemotherapy." @default.
• W2803400551 created "2018-06-01" @default.
• W2803400551 creator A5013973657 @default.
• W2803400551 creator A5035153885 @default.
• W2803400551 creator A5046910346 @default.
• W2803400551 creator A5061918886 @default.
• W2803400551 creator A5072861069 @default.
• W2803400551 creator A5079069279 @default.
• W2803400551 creator A5087784825 @default.
• W2803400551 creator A5088982549 @default.
• W2803400551 date "2018-05-26" @default.
• W2803400551 modified "2023-10-15" @default.
• W2803400551 title "Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis" @default.
• W2803400551 cites W1586634518 @default.
• W2803400551 cites W1618171273 @default.
• W2803400551 cites W2014401523 @default.
• W2803400551 cites W2044736010 @default.
• W2803400551 cites W2051497773 @default.
• W2803400551 cites W2073541926 @default.
• W2803400551 cites W2075981888 @default.
• W2803400551 cites W2088095316 @default.
• W2803400551 cites W2095261713 @default.
• W2803400551 cites W2102310008 @default.
• W2803400551 cites W2110125130 @default.
• W2803400551 cites W2125095427 @default.
• W2803400551 cites W2138747631 @default.
• W2803400551 cites W2151645021 @default.
• W2803400551 cites W2151730005 @default.
• W2803400551 cites W2155384808 @default.
• W2803400551 cites W2160109089 @default.
• W2803400551 cites W2170704231 @default.
• W2803400551 cites W2406683325 @default.
• W2803400551 cites W2526747727 @default.
• W2803400551 cites W2527325576 @default.
• W2803400551 cites W2565494552 @default.
• W2803400551 cites W2588073896 @default.
• W2803400551 cites W2592198365 @default.
• W2803400551 cites W2621266288 @default.
• W2803400551 cites W2917837889 @default.
• W2803400551 doi "https://doi.org/10.22034/apjcp.2018.19.5.1397" @default.
• W2803400551 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6031838" @default.
• W2803400551 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29802706" @default.
• W2803400551 hasPublicationYear "2018" @default.
• W2803400551 type Work @default.
• W2803400551 sameAs 2803400551 @default.
• W2803400551 citedByCount "3" @default.
• W2803400551 countsByYear W28034005512019 @default.
• W2803400551 countsByYear W28034005512022 @default.
• W2803400551 countsByYear W28034005512023 @default.
• W2803400551 crossrefType "journal-article" @default.
• W2803400551 hasAuthorship W2803400551A5013973657 @default.
• W2803400551 hasAuthorship W2803400551A5035153885 @default.
• W2803400551 hasAuthorship W2803400551A5046910346 @default.
• W2803400551 hasAuthorship W2803400551A5061918886 @default.
• W2803400551 hasAuthorship W2803400551A5072861069 @default.
• W2803400551 hasAuthorship W2803400551A5079069279 @default.
• W2803400551 hasAuthorship W2803400551A5087784825 @default.
• W2803400551 hasAuthorship W2803400551A5088982549 @default.
• W2803400551 hasConcept C121608353 @default.
• W2803400551 hasConcept C126322002 @default.
• W2803400551 hasConcept C143998085 @default.
• W2803400551 hasConcept C207103383 @default.
• W2803400551 hasConcept C2776694085 @default.
• W2803400551 hasConcept C2777063308 @default.
• W2803400551 hasConcept C2778496288 @default.
• W2803400551 hasConcept C2778570526 @default.
• W2803400551 hasConcept C2778997737 @default.
• W2803400551 hasConcept C2779998722 @default.
• W2803400551 hasConcept C44249647 @default.
• W2803400551 hasConcept C509974204 @default.
• W2803400551 hasConcept C526805850 @default.
• W2803400551 hasConcept C71924100 @default.
• W2803400551 hasConcept C82789193 @default.
• W2803400551 hasConcept C90924648 @default.
• W2803400551 hasConceptScore W2803400551C121608353 @default.
• W2803400551 hasConceptScore W2803400551C126322002 @default.
• W2803400551 hasConceptScore W2803400551C143998085 @default.
• W2803400551 hasConceptScore W2803400551C207103383 @default.
• W2803400551 hasConceptScore W2803400551C2776694085 @default.
• W2803400551 hasConceptScore W2803400551C2777063308 @default.
• W2803400551 hasConceptScore W2803400551C2778496288 @default.
• W2803400551 hasConceptScore W2803400551C2778570526 @default.
• W2803400551 hasConceptScore W2803400551C2778997737 @default.
• W2803400551 hasConceptScore W2803400551C2779998722 @default.
• W2803400551 hasConceptScore W2803400551C44249647 @default.
• W2803400551 hasConceptScore W2803400551C509974204 @default.
• W2803400551 hasConceptScore W2803400551C526805850 @default.
• W2803400551 hasConceptScore W2803400551C71924100 @default.
• W2803400551 hasConceptScore W2803400551C82789193 @default.
• W2803400551 hasConceptScore W2803400551C90924648 @default.
• W2803400551 hasIssue "5" @default.
• W2803400551 hasLocation W28034005511 @default.
• W2803400551 hasOpenAccess W2803400551 @default.
• W2803400551 hasPrimaryLocation W28034005511 @default.
• W2803400551 hasRelatedWork W2122582854 @default.
• W2803400551 hasRelatedWork W2359686091 @default.
• W2803400551 hasRelatedWork W2361990641 @default.
• W2803400551 hasRelatedWork W2374101007 @default.

• next